tiprankstipranks
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market

GlucoTrack (GCTK) Technical Analysis

26 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
GlucoTrack’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting GlucoTrack is a Buy.
GlucoTrack’s (GCTK) 20-Day exponential moving average is 0.56, while GlucoTrack’s (GCTK) share price is $0.55, making it a Sell.
GlucoTrack’s (GCTK) 50-Day exponential moving average is 0.48, while GlucoTrack’s (GCTK) share price is $0.55, making it a Buy.

GlucoTrack (GCTK) Pivot Points

May 15, 2024, 06:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.53
0.54
0.55
0.57
0.58
0.59
0.60
Fibonacci
0.54
0.55
0.56
0.57
0.58
0.58
0.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

May 15, 2024, 06:51 AM
Period
Simple
Exponential
MA5
0.56Sell
0.57Sell
MA10
0.58Sell
0.57Sell
MA20
0.61Sell
0.56Sell
MA50
0.46Buy
0.48Buy
MA100
0.35Buy
0.40Buy
MA200
0.30Buy
0.35Buy
GlucoTrack’s (GCTK) 10-Day exponential moving average is 0.57, while GlucoTrack’s (GCTK) share price is $0.55, making it a Sell.
GlucoTrack’s (GCTK) 100-Day exponential moving average is 0.40, while GlucoTrack’s (GCTK) share price is $0.55, making it a Buy.
GlucoTrack’s (GCTK) stock price is $0.55 and GlucoTrack’s (GCTK) 50-day simple moving average is 0.46, creating a Buy signal.
GlucoTrack’s (GCTK) stock price is $0.55 and GlucoTrack’s (GCTK) 100-day simple moving average is 0.35, creating a Buy signal.
GlucoTrack’s (GCTK) stock price is $0.55 and GlucoTrack’s (GCTK) 200-day simple moving average is 0.30, creating a Buy signal.

GlucoTrack (GCTK) Technical Indicators

May 15, 2024, 06:51 AM
Name
Value
Implied Action
RSI (14)
49.85
Neutral
STOCH (9,6)
17.25
Buy
STOCHRSI (14)
26.10
Neutral
MACD (12,26)
0.03
Buy
ADX (14)
26.25
Neutral
Williams %R
-69.64
Buy
CCI (14)
-38.53
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
41.96
Neutral
ROC
-28.95
Sell
GlucoTrack’s (GCTK) Relative Strength Index (RSI) is 49.85, creating a Neutral signal.
GlucoTrack’s (GCTK) Trend Strength Indicator (ADX) is 26.25, creating a Neutral signal.
GlucoTrack’s (GCTK) Commodity Channel Index (CCI) is -38.53, creating a Neutral signal.
GlucoTrack’s (GCTK) Price Rate of Change (ROC) is -28.95, creating a Sell signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Hold.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 49.85, which suggests GCTK is a Neutral.
      What is GCTK’s MACD?
      GCTK’s MACD is 0.03, which suggests GCTK is a Buy.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 0.56, which suggests GCTK is a Sell.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 0.61, which suggests GCTK is a Sell.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 0.46, which suggests GCTK is a Buy.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 0.30, which suggests GCTK is a Buy.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -69.64, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is -38.53, which suggests GCTK is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis